1. Home
  2. BMRN vs NBY Comparison

BMRN vs NBY Comparison

Compare BMRN & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$59.78

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$0.55

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMRN
NBY
Founded
1996
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
398.2M
IPO Year
1999
2007

Fundamental Metrics

Financial Performance
Metric
BMRN
NBY
Price
$59.78
$0.55
Analyst Decision
Buy
Analyst Count
21
0
Target Price
$89.86
N/A
AVG Volume (30 Days)
2.1M
1.9M
Earning Date
02-20-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
59.53
N/A
EPS
2.68
0.47
Revenue
$3,094,001,000.00
$10,302,000.00
Revenue This Year
$13.53
$23.91
Revenue Next Year
$9.69
$32.05
P/E Ratio
$22.36
$23.40
Revenue Growth
12.39
390.34
52 Week Low
$50.76
$0.46
52 Week High
$73.51
$19.95

Technical Indicators

Market Signals
Indicator
BMRN
NBY
Relative Strength Index (RSI) 63.45 35.04
Support Level $57.84 $0.57
Resistance Level $61.48 $0.72
Average True Range (ATR) 1.69 0.32
MACD 0.36 -0.21
Stochastic Oscillator 85.00 1.54

Price Performance

Historical Comparison
BMRN
NBY

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: